李明珠;徐良成;张勇;

• 1:江苏省连云港市第一人民医院

摘要(Abstract)：

替罗非班是一种可逆性糖蛋白Ⅱb/Ⅲa受体拮抗剂,具有抑制血小板聚集、延长出血时间、减少血栓形成等作用,但其具有潜在的致血小板减少及出血风险。本文报道了1例经皮冠状动脉介入术(PCI)后应用替罗非班所致极重度血小板减少症患者,以提高临床医生对替罗非班致极重度血小板减少症的认识。

关键词(KeyWords)： 血小板减少;替罗非班;病例报告

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李明珠;徐良成;张勇;

Email:

DOI:

参考文献(References)：

• [1]RAHMAN N,JAFARY F H.Vanishing platelets:rapid and extreme tirofiban-induced thrombocytopenia after percutaneous coronary intervention for acute myocardial infarction[J].Tex Heart Inst J,2010,37(1):109-112.
• [2]BALAMUTHUSAMY S,ARORA R.Hematologic adverse effects of clopidogrel[J].Am J Ther,2007,14(1):106-112.DOI:10.1097/01.mjt.0000212708.81034.22.
• [3]SALTER B S,WEINER M M,TRINH M A,et al.HeparinInduced Thrombocytopenia:A Comprehensive Clinical Review[J].J Am Coll Cardiol,2016,67(21):2519-2532.DOI:10.1016/j.jacc.2016.02.073.
• [4]KHANDELWAL S,AREPALLY G M.Immune pathogenesis of heparin-induced thrombocytopenia[J].Thromb Haemost,2016,116(5):792-798.DOI:10.1160/TH16-01-0074.
• [5]AHMED I,MAJEED A,POWELL R.Heparin induced thrombocytopenia:diagnosis and management update[J].Postgrad Med J,2007,83(983):575-582.DOI:10.1136/pgmj.2007.059188.
• [6]徐立,杨新春,王乐丰,等.急性心肌梗死急诊介入治疗联合应用替罗非班发生血小板减少症的临床分析—替罗非班可能的副作用[J].中国介入心脏病学杂志,2008,16(1):5-7.DOI:10.3969/j.issn.1004-8812.2008.01.002.
• [7]ABRAMS C S,CINES D B.Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors[J].Curr Hematol Rep,2004,3(2):143-147.
• [8]BILLHEIMER J T,DICKER I B,WYNN R,et al.Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated[J].Blood,2002,99(10):3540-3546.
• [9]AL-JAFAR H,AL-YOUSEF A,AL-SHATTI S,et al.DrugImmune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia:A Critical Clinical Controversy[J].Case Rep Nephrol Dial,2015,5(2):152-159.DOI:10.1159/000435806.
• [10]SAID S M,HAHN J,SCHLEYER E,et al.Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia:diagnosis and treatment[J].Clin Res Cardiol,2007,96(2):61-69.DOI:10.1007/s00392-006-0459-7.
• [11]ADAMO M,ARIOTTI S,COSTA F,et al.Phosphate-or CitrateBuffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome:A Post Hoc Analysis From the PRISM Trial[J].JACC Cardiovasc Interv,2016,9(16):1667-1676.DOI:10.1016/j.jcin.2016.05.031.

文章评论(Comment)：